Removal of the glycosylphosphatidylinositol anchor from PrPSc by cathepsin D does not reduce prion infectivity

被引:17
作者
Lewis, PA
Properzi, F
Prodromidou, K
Clarke, AR
Collinge, J
Jackson, GS
机构
[1] UCL, Inst Neurol, Dept Neurodegenerat Dis, MRC Prion Unit, London WC1N 3BG, England
[2] Univ Bristol, Sch Med Sci, Dept Biochem, Bristol BS8 1TD, Avon, England
基金
英国医学研究理事会;
关键词
cathepsin D; Creutzfeldt-Jakob disease (CJD); glycosylphosphatidylinositol; anchor (GPI anchor); prion; prion infectivity;
D O I
10.1042/BJ20051677
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
According to the protein-only hypothesis of prion propagation, prions are composed principally of PrP(Sc), an abnormal conformational isoform of the prion protein, which, like its normal cellular precursor (PrP(C)), has a GPI (glycosylphosphatidylinositol) anchor at the C-terminus. To date, elucidating the role of this anchor on the infectivity of prion preparations has not been possible because of the resistance of PrP(Sc) to the activity of PI-PLC (phosphoinositide specific phospholipase C), an enzyme which removes the GPI moiety from PrPc. Removal of the GPI anchor from PrP(Sc) requires denaturation before treatment with PI-PLC, a process that also abolishes infectivity. To circurrivent this problem, we have removed the GPI anchor from PrP(Sc) in RML (Rocky Mountain Laboratory)-prion-infected murine brain homogenate using the aspartic endoprotease cathepsin D. This enzyme eliminates a short sequence at the C-terminal end of PrP to which the GPI anchor is attached. We found that this modification has no effect (i) on an in vitro amplification model of PrP(Sc), (ii) on the prion titre as determined by a highly sensitive N2a-cell based bioassay, or (iii) in a mouse bioassay. These results show that the GPI anchor has little or no role in either the propagation of PrP(Sc) or on prion infectivity.
引用
收藏
页码:443 / 448
页数:6
相关论文
共 43 条
[21]   A quantitative, highly sensitive cell-based infectivity assay for mouse scrapie prions [J].
Klöhn, PC ;
Stoltze, L ;
Flechsig, E ;
Enari, M ;
Weissmann, C .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (20) :11666-11671
[22]   CELL-FREE FORMATION OF PROTEASE-RESISTANT PRION PROTEIN [J].
KOCISKO, DA ;
COME, JH ;
PRIOLA, SA ;
CHESEBRO, B ;
RAYMOND, GJ ;
LANSBURY, PT ;
CAUGHEY, B .
NATURE, 1994, 370 (6489) :471-474
[23]   Synthetic mammalian prions [J].
Legname, G ;
Baskakov, IV ;
Nguyen, HOB ;
Riesner, D ;
Cohen, FE ;
DeArmond, SJ ;
Prusiner, SB .
SCIENCE, 2004, 305 (5684) :673-676
[24]   A MUTANT PRION PROTEIN DISPLAYS AN ABERRANT MEMBRANE ASSOCIATION WHEN EXPRESSED IN CULTURED-CELLS [J].
LEHMANN, S ;
HARRIS, DA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (41) :24589-24597
[25]   HUMAN PRION PROTEIN CDNA - MOLECULAR-CLONING, CHROMOSOMAL MAPPING, AND BIOLOGICAL IMPLICATIONS [J].
LIAO, YCJ ;
LEBO, RV ;
CLAWSON, GA ;
SMUCKLER, EA .
SCIENCE, 1986, 233 (4761) :364-367
[26]   Intercellular transfer of the cellular prion protein [J].
Liu, T ;
Li, RL ;
Pan, T ;
Liu, DC ;
Petersen, RB ;
Wong, BS ;
Gambetti, P ;
Sy, MS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (49) :47671-47678
[27]   DETECTION OF APOPTOSIS IN MURINE SCRAPIE [J].
LUCASSEN, PJ ;
WILLIAMS, A ;
CHUNG, WCJ ;
FRASER, H .
NEUROSCIENCE LETTERS, 1995, 198 (03) :185-188
[28]   In vitro amplification of protease-resistant prion protein requires free sulfhydryl groups [J].
Lucassen, R ;
Nishina, K ;
Supattapone, S .
BIOCHEMISTRY, 2003, 42 (14) :4127-4135
[29]   Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis [J].
Mallucci, G ;
Dickinson, A ;
Linehan, J ;
Klöhn, PC ;
Brandner, S ;
Collinge, J .
SCIENCE, 2003, 302 (5646) :871-874
[30]   Prion proteins carrying pathogenic mutations are resistant to phospholipase cleavage of their glycolipid anchors [J].
Narwa, R ;
Harris, DA .
BIOCHEMISTRY, 1999, 38 (27) :8770-8777